title: Early adolescent executive functioning, intrauterine exposures and own drug use.
abstract: Individual differences in adolescents' executive functioning are often attributed either to intrauterine substance exposure or to adolescents' own substance use, but both predictors typically have not been evaluated simultaneously in the same study. This prospective study evaluated whether intrauterine drug exposures, the adolescents' own substance use, and/or their potential interactions are related to poorer executive functioning after controlling for important contextual variables. Analyses were based on data collected on a sample of 137 predominantly African-American/African Caribbean adolescents from low-income urban backgrounds who were followed since their term birth. Intrauterine substance exposures (cocaine, marijuana, alcohol, and cigarettes) and adolescents' substance use were documented using a combination of biological assays and maternal and adolescent self-report. At 12-14 years of age, examiners masked to intrauterine exposures and current substance use assessed the adolescents using the Delis-Kaplan Executive Function System (D-KEFS), an age-referenced instrument evaluating multiple dimensions of executive functioning (EF). Results of covariate-controlled analyses in this study suggest that when intrauterine substance exposures and young adolescents' substance use variables were in the same analysis models, subtle differences in specific EF outcomes were identifiable in this non-referred sample. While further study with larger samples is indicated, these findings suggest that 1) research on adolescent substance use and intrauterine exposure research should evaluate both predictors simultaneously, 2) subtle neurocognitive effects associated with specific intrauterine drug exposures can be identified during early adolescence, and 3) intrauterine substance exposure effects may differ from those associated with adolescents' own drug use.
authors.affiliation: Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, 88 East Newton Street, Boston, MA 02118, United States. rrosejac@bu.edu
authors.forename: Ruth
authors.initials: R
authors.lastname: Rose-Jacobs
authors.forename: Shayna
authors.initials: S
authors.lastname: Soenksen
authors.forename: Danielle P
authors.initials: DP
authors.lastname: Appugliese
authors.forename: Howard J
authors.initials: HJ
authors.lastname: Cabral
authors.forename: Mark A
authors.initials: MA
authors.lastname: Richardson
authors.forename: Marjorie
authors.initials: M
authors.lastname: Beeghly
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Heeren
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Frank
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior / Q000187:drug effects* / Q000523:psychology*; D003071:Cognition / Q000187:drug effects*; D005260:Female; D006801:Humans; D013287:Illicit Drugs / Q000633:toxicity*; D008297:Male; D008404:Massachusetts; D015999:Multivariate Analysis; D009483:Neuropsychological Tests; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced / Q000523:psychology*; D011446:Prospective Studies; D012959:Socioeconomic Factors; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000523:psychology*
chemical_list: D013287:Illicit Drugs